NCT04727775View on ClinicalTrials.gov

Antiviral Drugs on the Treatment of SARS-CoV-2

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

July 25, 2023

Study Completion Date

July 25, 2023

Conditions
Complication of Medical CarePneumonia, Viral
Interventions
DRUG

Favipiravir

Antiviral drugs

DRUG

Remdesivir

Antiviral drugs

Trial Locations (2)

010000

Aidos Konkaev, Astana

071407

Semey Medical University, Semey

All Listed Sponsors
lead

Astana Medical University

OTHER

NCT04727775 - Antiviral Drugs on the Treatment of SARS-CoV-2 | Biotech Hunter | Biotech Hunter